• Title/Summary/Keyword: central reduced rings

Search Result 6, Processing Time 0.02 seconds

On a Class of Semicommutative Rings

  • Ozen, Tahire;Agayev, Nazim;Harmanci, Abdullah
    • Kyungpook Mathematical Journal
    • /
    • v.51 no.3
    • /
    • pp.283-291
    • /
    • 2011
  • In this paper, a generalization of the class of semicommutative rings is investigated. A ring R is called central semicommutative if for any a, b ${\in}$ R, ab = 0 implies arb is a central element of R for each r ${\in}$ R. We prove that some results on semicommutative rings can be extended to central semicommutative rings for this general settings.

ON NEAR-RINGS WITH STRONG REGULARITY

  • Cho, Yong-Uk
    • The Pure and Applied Mathematics
    • /
    • v.17 no.2
    • /
    • pp.131-136
    • /
    • 2010
  • Throught this paper, we will investigate some properties of left regular and strongly reduced near-rings. Mason introduced the notion of left regularity and he characterized left regular zero-symmetric unital near-rings. Also, this concept have been studied by several authors. The purpose of this paper is to find some characterizations of the strong reducibility in near-rings, and the strong regularity in near-rings which are closely related with strongly reduced near-rings.

ON STRONG REGULARITY AND RELATED CONCEPTS

  • Cho, Yong-Uk
    • Journal of applied mathematics & informatics
    • /
    • v.28 no.1_2
    • /
    • pp.509-513
    • /
    • 2010
  • In this paper, we will investigate some properties of strongly reduced near-rings. The purpose of this paper is to find more characterizations of the strong regularity in near-rings, which are closely related with strongly reduced near-rings.

Effects of Kanagawa Hemolysin on Blood Pressure and Arterial Tone in Rats

  • Kim, Young-Moon
    • The Korean Journal of Physiology and Pharmacology
    • /
    • v.6 no.4
    • /
    • pp.225-233
    • /
    • 2002
  • Kanagawa hemolysin (KH), an exotoxin produced from Kanagawa phenomenon-positive Vibrio parahemolyticus, has been shown to possess various biological activities including hemolysis, enterotoxicity, cytotoxicity, and cardiotoxicity. The aim of this study was to investigate the effect of KH on the cardiovascular system and its mechanism, employing in vivo and in vitro experiments of the rat. Intracerebroventricular (icv) administration of 100 mHU KH produced a marked and continuous pressor effect (icv KH-pressor effect), and the icv pressor effect was not repeatable. However, intravenous (iv) injection of the same dose of KH induced a prominent depressor effect (iv KH-depressor effect). The icv KH-pressor effect was inhibited by acid-denaturation, while the iv KH-depressor effect was not. Simultaneous icv administration of the three agents (ouabain, diltiazem, or bumetanide: $10{\mu}g/kg$ each) significantly reduced the pressor effect. The icv KH-pressor effect was inhibited by treatment with iv phentolamine or chlorisondamine, but was not affected by iv candesartan. The iv KH-depressor effect was repeatable and was attenuated by treatment with iv NAME or methylene blue. In vitro experiments using isolated thoracic aorta, $10^{-6}$ M phenylephrine (PE) and 50 mM KCl produced a sustained contraction. In rings contracted with either agents, KH showed relaxant responses in a concentration- dependent fashion and the relaxation (KH-vasorelaxation) was not dependent on the existence of the endothelium. The KH-vasorelaxation in the endothelium-intact rings contracted by PE was abolished by methylene blue treatment. In summary, the present findings suggest that in the icv KH-pressor effect the cation leak-inducing action of KH is implicated, which leads to the increased central sympathetic tone, that the iv KH-depressor effect results from the vasorelaxation via NO-guanylate cyclase system, and that the KH-vasorelaxation is independent of the endothelium and the guanylate cyclase system is involved in it. In conclusion, the mechanism of KH producing the icv pressor effect may not be identical to that of KH producing the iv depressor effect.

Superoxide and Nitric Oxide Involvement in Enhancing of N-methyl-D-aspartate Receptor-Mediated Central Sensitization in the Chronic Post-ischemia Pain Model

  • Ryu, Tae-Ha;Jung, Kyung-Young;Ha, Mi-Jin;Kwak, Kyung-Hwa;Lim, Dong-Gun;Hong, Jung-Gil
    • The Korean Journal of Pain
    • /
    • v.23 no.1
    • /
    • pp.1-10
    • /
    • 2010
  • Background: Recent studies indicate that reactive oxygen species (ROS) are involved in persistent pain, including neuropathic and inflammatory pain. Since the data suggest that ROS are involved in central sensitization, the present study examines the levels of activated N-methyl-D-aspartate (NMDA) receptors in the dorsal horn after an exogenous supply of three antioxidants in rats with chronic post-ischemia pain (CPIP). This serves as an animal model of complex regional pain syndrome type-I induced by hindpaw ischemia/reperfusion injury. Methods: The application of tight-fitting O-rings for a period of three hours produced CPIP in male Sprague-Dawley rats. Allopurinol 4 mg/kg, allopurinol 40 mg/kg, superoxide dismutase (SOD) 4,000 U/kg, N-nitro-L-arginine methyl ester (L-NAME) 10 mg/kg and SOD 4,000 U/kg plus L-NAME 10 mg/kg were administered intraperitoneally just after O-ring application and on the first and second days after reperfusion. Mechanical allodynia was measured, and activation of the NMDA receptor subunit 1 (pNR1) of the lumbar spinal cord (L4-L6) was analyzed by the Western blot three days after reperfusion. Results: Allopurinol reduced mechanical allodynia and attenuated the enhancement of spinal pNR1 expression in CPIP rats. SOD and L-NAME also blocked spinal pNR1 in accordance with the reduced mechanical allodynia in rats with CPIP. Conclusions: The present data suggest the contribution of superoxide, produced via xanthine oxidase, and the participation of superoxide and nitric oxide as a precursor of peroxynitrite in NMDA mediated central sensitization. Finally, the findings support a therapeutic potential for the manipulation of superoxide and nitric oxide in ischemia/reperfusion related pain conditions.